Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Qualigen Therapeutics Inc (QLGN)
:QLGN
Holding QLGN?
Track your performance easily
QLGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.34 - $29.41
Previous CloseN/A
Volume8.82K
Average Volume (3M)27.57K
Market Cap
$2.95M
Enterprise Value$2.86M
Total Cash (Recent Filing)$153.12K
Total Debt (Recent Filing)$305.81K
Price to Earnings (P/E)―
Beta1.50
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-55.30
Shares Outstanding736,431
10 Day Avg. Volume17,424
30 Day Avg. Volume27,565
Standard Deviation0.36
R-Squared0.01
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market Cap0.97
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Qualigen Therapeutics News
PremiumCompany Announcements
Qualigen Therapeutics Appoints Graydon Bensler to Board
PremiumCompany Announcements
Qualigen Therapeutics Announces 1-for-50 Reverse Stock Split
PremiumCompany Announcements
Qualigen Therapeutics Board Experiences Key ChangesOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.97% Mutual Funds
― Other Institutional Investors
96.03% Public Companies and Individual Investors
QLGN FAQ
What was Qualigen Therapeutics Inc’s price range in the past 12 months?
Qualigen Therapeutics Inc lowest stock price was $3.33 and its highest was $29.41 in the past 12 months.
What is Qualigen Therapeutics Inc’s market cap?
Qualigen Therapeutics Inc’s market cap is $2.95M.
When is Qualigen Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Qualigen Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Qualigen Therapeutics Inc overvalued?
According to Wall Street analysts Qualigen Therapeutics Inc’s price is currently Overvalued.
Does Qualigen Therapeutics Inc pay dividends?
Qualigen Therapeutics Inc does not currently pay dividends.
What is Qualigen Therapeutics Inc’s EPS estimate?
Qualigen Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qualigen Therapeutics Inc have?
Qualigen Therapeutics Inc has 736,431 shares outstanding.
What happened to Qualigen Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Qualigen Therapeutics Inc?
Currently, no hedge funds are holding shares in QLGN
---
Company Description
Qualigen Therapeutics Inc
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.
---
Technical Analysis
---